Description

Product Name: Tirzepatide 60mg (RUO)

Form: Lyophilized powder
Quantity: 66.6 mg per vial/3mL

Appearance: White to off-white powder
Storage: Store at -20°C. Reconstituted solutions should be handled under sterile laboratory conditions.

Intended Use: This product is provided strictly for qualified research professionals. It is intended for in-vitro research and development purposes only.

Amino Acid Sequence: YE-Aib-GTFTSDYSI-Aib-LDKIAQ (C20 fatty
acid) AFVQWLIAGGPSSGAPPPS
Note: Aib is a non-coded (non-proteinogenic) amino acid – H2H-C(CH3)2-COOH
Molecular Formula: C225H348N4gO68
Molecular Weight: 4813.527 g/mol
Synonyms: Tirzepatide, P1206, LY3298176, BG 121, Dual GIP and GLP-1 receptor
agonist (GIP/GLP-1RA)

Tirzepatide is a synthetic peptide with glucose-lowering effects. It works to stimulate first- and second-phase insulin secretion, and reduces glucagon levels, both in a glucose-dependent manner. Tirzepatide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake, and reduce body weight in patients with type 2 diabetes. Tirzepatide can increase insulin sensitivity. As the peptide is conjugated to a C20 fatty diacid moiety through a hydrophilic linker at the lysine residue at position 20, the drug is highly bound to albumin in the plasma, which prolongs its half-life.

Source:PubChem

⚠️ Disclaimer: Research Use Only. Not for human consumption, medical, or veterinary use. The Cosmic Root LLC assumes no responsibility for misuse of this product.